CD44 and breast cancer: By using a tumour xenograft originating from a human basal-like breast cancer, we show that the eradication of the large bulk of tumour cells by chemotherapy is associated with the presence of CD44+ cancer cells, suggesting that a subpopulation of CD44+ tumour cells survives in spite of the macroscopic complete tumour remission induced by chemotherapy.